Free Trial

Ambev (NYSE:ABEV) Shares Unloaded Rep. Josh Gottheimer

Ambev logo with Consumer Staples background

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Ambev S.A. NYSE: ABEV. In a filing disclosed on January 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Ambev stock on December 27th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

Representative Josh Gottheimer also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of Block NYSE: SQ on 12/30/2024.
  • Purchased $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 12/30/2024.
  • Sold $1,001 - $15,000 in shares of Grupo Financiero Banorte OTCMKTS: GBOOY on 12/27/2024.
  • Sold $1,001 - $15,000 in shares of Cadre NYSE: CDRE on 12/27/2024.
  • Sold $1,001 - $15,000 in shares of Coloplast A/S OTCMKTS: CLPBY on 12/27/2024.
  • Sold $1,001 - $15,000 in shares of Intuitive Surgical NASDAQ: ISRG on 12/23/2024.
  • Sold $1,001 - $15,000 in shares of Trane Technologies NYSE: TT on 12/23/2024.
  • Purchased $1,001 - $15,000 in shares of Walmart NYSE: WMT on 12/20/2024.
  • Sold $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 12/19/2024.
  • Purchased $1,001 - $15,000 in shares of Walmart NYSE: WMT on 12/19/2024.

Ambev Stock Performance

Shares of ABEV stock traded down $0.05 during mid-day trading on Thursday, hitting $1.81. The stock had a trading volume of 42,349,083 shares, compared to its average volume of 50,974,188. The firm has a market cap of $28.44 billion, a PE ratio of 10.03, a PEG ratio of 5.23 and a beta of 1.05. The company's 50-day simple moving average is $2.06 and its 200-day simple moving average is $2.19. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.20 and a quick ratio of 0.89. Ambev S.A. has a fifty-two week low of $1.76 and a fifty-two week high of $2.73.

Ambev Cuts Dividend

The company also recently disclosed an annual dividend, which was paid on Thursday, January 9th. Shareholders of record on Monday, December 23rd were paid a $0.0414 dividend. The ex-dividend date was Monday, December 23rd. This represents a yield of 1.93%. Ambev's dividend payout ratio is currently 38.89%.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Ambev in a report on Saturday, January 11th. They issued a "buy" rating for the company.

Get Our Latest Report on Ambev

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Prime Capital Investment Advisors LLC boosted its stake in shares of Ambev by 37.9% during the 3rd quarter. Prime Capital Investment Advisors LLC now owns 17,685 shares of the company's stock worth $43,000 after acquiring an additional 4,861 shares in the last quarter. UMB Bank n.a. raised its holdings in Ambev by 37.4% during the third quarter. UMB Bank n.a. now owns 18,324 shares of the company's stock worth $45,000 after purchasing an additional 4,984 shares during the last quarter. PDS Planning Inc boosted its position in Ambev by 18.4% during the third quarter. PDS Planning Inc now owns 34,870 shares of the company's stock worth $85,000 after purchasing an additional 5,409 shares in the last quarter. Park Avenue Securities LLC grew its holdings in Ambev by 23.8% in the third quarter. Park Avenue Securities LLC now owns 28,787 shares of the company's stock valued at $70,000 after purchasing an additional 5,526 shares during the last quarter. Finally, Endowment Wealth Management Inc. increased its position in shares of Ambev by 21.6% in the third quarter. Endowment Wealth Management Inc. now owns 31,525 shares of the company's stock valued at $77,000 after buying an additional 5,592 shares in the last quarter. 8.13% of the stock is currently owned by institutional investors and hedge funds.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2025. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2024 election. Gottheimer was first elected to the House in 2016. Prior to his election, Gottheimer worked for Microsoft, the Federal Communications Commission, and for the administration of President Bill Clinton (D). Click here for more information about Gottheimer's career. Gottheimer serves on the House Financial Services Committee, where is a member of three subcommittees. For more on Gottheimer's committee assignments, click here. Gottheimer became a co-chair of the Problem Solvers Caucus in February 2017. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

Ambev Company Profile

(Get Free Report)

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

See Also

Should You Invest $1,000 in Ambev Right Now?

Before you consider Ambev, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.

While Ambev currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines